SlideShare uma empresa Scribd logo
1 de 2
Baixar para ler offline
Epilepsy Drug Gabapentin Shows Promise In Treating
Alcohol Dependence
By Megan Gannon, News Editor
Published: 11/07/2013 08:55 AM EST on LiveScience
A drug typically used to treat epilepsy may also be
effective in treating alcoholism, the results of a clinical
trial suggest.
Alcohol-dependent patients who took gabapentin, an
anticonvulsant medication, were more likely to stop
drinking or at least abstain from heavy drinking than
those taking a placebo, the study found. What's more,
participants receiving gabapentin also slept better,
showed improvements in mood and had fewer alcohol
cravings, with few side effects, the researchers said.
According to the National Institutes of Health (NIH), 18 million people in the United States are
affected by alcohol-use disorders, but there are few drug options available. [7 Ways Alcohol Affects
Your Health]
There are just three medications used to treat alcohol dependence that have been approved by the
Food and Drug Administration. One drug called disulfiram discourages drinking by making it quite
unpleasant -- it blocks the metabolism of alcohol and causes nausea, vomiting and other nasty side
effects when a person drinks.
Another medication, acamprosate, is thought to help restore the chemical balance in the brains of
alcohol-dependent people after they stop drinking, and the third, naltrexone, blocks the brain's opiod
receptors and has been shown to ease addicts' cravings for drugs and alcohol.
Gabapentin showed similar or greater positive outcomes compared with these existing treatments,
said study researcher Barbara Mason, of the Scripps Research Institute in La Jolla, Calif.
"Plus, it's the only medication shown to improve sleep and mood in people who are quitting or
reducing their drinking, and it's already widely used in primary care -- that's an appealing
combination," Mason explained in a statement.
Patients in the trial were randomly assigned to receive a moderate dose (900 milligrams) or high
dose (1,800 milligrams) of gabapentin, or a placebo during a 12-week course of treatment.
Compared with people in the placebo group, alcohol-dependent participants using the high dose of
gabapentin were twice as likely to refrain from heavy drinking, and four times as likely to stop
drinking altogether, the researchers said. The smaller dose of gabapentin produced less dramatic
results.
The researchers reported that patients in the clinical trial experienced few negative side effects. The
NIH says the side effects of gabapentin include drowsiness, anxiety, headaches and nausea.
The National Institute on Alcohol Abuse and Alcoholism, part of the NIH, funded the study. It was
detailed this month in the journal JAMA Internal Medicine.
Follow Megan Gannon on Twitter and Google+. Follow us @livescience, Facebook Google+. Original
article on LiveScience.
Copyright 2013 LiveScience, a TechMediaNetwork company. All rights reserved. This material may
not be published, broadcast, rewritten or redistributed. ]]

Mais conteúdo relacionado

Destaque

Shivaji shinde colloquium ppt..
Shivaji shinde colloquium ppt..Shivaji shinde colloquium ppt..
Shivaji shinde colloquium ppt..sushiv
 
Neurontin 100 mg buy soma online -buyfioricetonlinefast
Neurontin 100 mg  buy soma online -buyfioricetonlinefastNeurontin 100 mg  buy soma online -buyfioricetonlinefast
Neurontin 100 mg buy soma online -buyfioricetonlinefastVipin Divakar
 
Gabapentin and pregablin
Gabapentin and pregablinGabapentin and pregablin
Gabapentin and pregablinDuraid Khalid
 
Gabapentin presentation
Gabapentin presentationGabapentin presentation
Gabapentin presentationmichaelgill77
 
Gralise (Gabapentin ER)
Gralise (Gabapentin ER)Gralise (Gabapentin ER)
Gralise (Gabapentin ER)KyleAmelung
 
Pain management after joint replacement surgery
Pain management after joint replacement surgeryPain management after joint replacement surgery
Pain management after joint replacement surgeryPranav Bansal
 
Drug Monitoring and Pharmacokinetics of Gabapentin, Clinical Pharmacy
Drug Monitoring and Pharmacokinetics of Gabapentin, Clinical PharmacyDrug Monitoring and Pharmacokinetics of Gabapentin, Clinical Pharmacy
Drug Monitoring and Pharmacokinetics of Gabapentin, Clinical Pharmacyİsa Badur
 
Drugs power point
Drugs power pointDrugs power point
Drugs power pointMATTY_666
 

Destaque (12)

Shivaji shinde colloquium ppt..
Shivaji shinde colloquium ppt..Shivaji shinde colloquium ppt..
Shivaji shinde colloquium ppt..
 
Neuropathic paintx
Neuropathic paintxNeuropathic paintx
Neuropathic paintx
 
Neurontin 100 mg buy soma online -buyfioricetonlinefast
Neurontin 100 mg  buy soma online -buyfioricetonlinefastNeurontin 100 mg  buy soma online -buyfioricetonlinefast
Neurontin 100 mg buy soma online -buyfioricetonlinefast
 
Introduction 2
Introduction 2Introduction 2
Introduction 2
 
Gabapentin and pregablin
Gabapentin and pregablinGabapentin and pregablin
Gabapentin and pregablin
 
diabetic neuropathy
diabetic neuropathydiabetic neuropathy
diabetic neuropathy
 
Diabetic Neuropathy
Diabetic NeuropathyDiabetic Neuropathy
Diabetic Neuropathy
 
Gabapentin presentation
Gabapentin presentationGabapentin presentation
Gabapentin presentation
 
Gralise (Gabapentin ER)
Gralise (Gabapentin ER)Gralise (Gabapentin ER)
Gralise (Gabapentin ER)
 
Pain management after joint replacement surgery
Pain management after joint replacement surgeryPain management after joint replacement surgery
Pain management after joint replacement surgery
 
Drug Monitoring and Pharmacokinetics of Gabapentin, Clinical Pharmacy
Drug Monitoring and Pharmacokinetics of Gabapentin, Clinical PharmacyDrug Monitoring and Pharmacokinetics of Gabapentin, Clinical Pharmacy
Drug Monitoring and Pharmacokinetics of Gabapentin, Clinical Pharmacy
 
Drugs power point
Drugs power pointDrugs power point
Drugs power point
 

Epilepsy Drug Gabapentin Shows Promise In Treating Alcohol Dependence

  • 1. Epilepsy Drug Gabapentin Shows Promise In Treating Alcohol Dependence By Megan Gannon, News Editor Published: 11/07/2013 08:55 AM EST on LiveScience A drug typically used to treat epilepsy may also be effective in treating alcoholism, the results of a clinical trial suggest. Alcohol-dependent patients who took gabapentin, an anticonvulsant medication, were more likely to stop drinking or at least abstain from heavy drinking than those taking a placebo, the study found. What's more, participants receiving gabapentin also slept better, showed improvements in mood and had fewer alcohol cravings, with few side effects, the researchers said. According to the National Institutes of Health (NIH), 18 million people in the United States are affected by alcohol-use disorders, but there are few drug options available. [7 Ways Alcohol Affects Your Health] There are just three medications used to treat alcohol dependence that have been approved by the Food and Drug Administration. One drug called disulfiram discourages drinking by making it quite unpleasant -- it blocks the metabolism of alcohol and causes nausea, vomiting and other nasty side effects when a person drinks. Another medication, acamprosate, is thought to help restore the chemical balance in the brains of alcohol-dependent people after they stop drinking, and the third, naltrexone, blocks the brain's opiod receptors and has been shown to ease addicts' cravings for drugs and alcohol. Gabapentin showed similar or greater positive outcomes compared with these existing treatments, said study researcher Barbara Mason, of the Scripps Research Institute in La Jolla, Calif. "Plus, it's the only medication shown to improve sleep and mood in people who are quitting or reducing their drinking, and it's already widely used in primary care -- that's an appealing combination," Mason explained in a statement. Patients in the trial were randomly assigned to receive a moderate dose (900 milligrams) or high dose (1,800 milligrams) of gabapentin, or a placebo during a 12-week course of treatment. Compared with people in the placebo group, alcohol-dependent participants using the high dose of gabapentin were twice as likely to refrain from heavy drinking, and four times as likely to stop drinking altogether, the researchers said. The smaller dose of gabapentin produced less dramatic
  • 2. results. The researchers reported that patients in the clinical trial experienced few negative side effects. The NIH says the side effects of gabapentin include drowsiness, anxiety, headaches and nausea. The National Institute on Alcohol Abuse and Alcoholism, part of the NIH, funded the study. It was detailed this month in the journal JAMA Internal Medicine. Follow Megan Gannon on Twitter and Google+. Follow us @livescience, Facebook Google+. Original article on LiveScience. Copyright 2013 LiveScience, a TechMediaNetwork company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. ]]